Asymptomatic Carotid Stenosis and Mobility Function With Exercise Intervention

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-89
SponsorVA Office of Research and Development

About this trial

Moderate (50-69%) asymptomatic carotid artery stenosis (ACAS) is an important and under-appreciated contributor to balance and mobility dysfunction. This is significant because declines in balance and mobility are a significant predictor of falls, disability, loss of independence, and death in older adults. Further, falls and fall-related injuries in older adults cost approximately 50 billion dollars annually in the United States, and are the leading cause of adverse events reported by the Veterans Health Administration. This proposal seeks to: 1) investigate the impact of a supervised aerobic and challenging balance exercise program on balance and mobility function in patients with moderate ACAS; and 2) elucidate whether these changes are related to changes in cerebral perfusion. With 830,000 Veterans estimated to have moderate ACAS and at risk for balance and mobility dysfunction and increased falls, the findings from this study could have significant impacts on the clinical management, quality of life, and functional independence of Veterans with moderate ACAS.

Eligibility criteria

Qualifiers

Eligible patients will be at least 18 years of age and will have asymptomatic 50-69% carotid stenosis

Asymptomatic status will be confirmed as in NIH trials on asymptomatic carotid stenosis, by medical history, physical examination, and the National Institutes of Health Stroke Scale (NIHSS)

Stenosis severity will be determined by duplex sonography, MR angiography, or CT angiography

Disqualifiers

previous stroke or transient ischemic attack

occlusion or severe stenosis of the non-index carotid artery

planned carotid revascularization

persons advised by their doctor not to exercise

Trial design

Treatments tested in this trial

  • Exercise Intervention

Treatment groups

50 Participants
are divided into 2 treatment groups